Guggenheim raised the firm's price target on Live Nation to $197 from $192 and keeps a Buy rating on the shares. The firm's 2026 adjusted operating income outlook is now $2.73B, up from $2.67B previously, reflecting the Q1 beat and "robust outlook for the remainder of the year," the analyst tells investors in a post-earnings note.
